W World Corp. Share · US92942B1035 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of W World Corp.
No Price
Company Profile for W World Corp. Share
W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.
Company Data
Name W World Corp.
Company W World Corp.
Website
https://www.pharmoscorp.com
Primary Exchange 
UTC
UTC
ISIN US92942B1035
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Eric W. Fangmann
Market Capitalization 80 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 3609 Hammerkop Drive, 89084 North Las Vegas
IPO Date 1983-08-05
Stock Splits
| Date | Split |
|---|---|
| 03.08.2020 | 1:200 |
| 31.05.2005 | 1:5 |
| 18.10.1993 | 1:4 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | WWHC |
More Shares
Investors who hold W World Corp. also have the following shares in their portfolio:
